Cargando…

Abacavir antiretroviral therapy and indices of subclinical vascular disease in persons with HIV

OBJECTIVE: Indices of cardiovascular disease (CVD) risk, vascular endothelial dilation, arterial stiffness and endothelial repair were examined in persons with HIV (PWH) on an antiretroviral therapy (ART) that included abacavir (ABC+) in comparison with PWH on ART without abacavir (ABC-), and with H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez, Claudia A., Rikhi, Rishi, Pester, Mollie S., Parker, Meela, Gonzalez, Alex, Larson, Michaela, Chavez, Jennifer, Mendez, Armando, Raines, Jeffrey K., Kolber, Michael A., Schulman, Ivonne H., Alcaide, Maria L., Hurwitz, Barry E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912137/ https://www.ncbi.nlm.nih.gov/pubmed/35271614 http://dx.doi.org/10.1371/journal.pone.0264445

Ejemplares similares

963. Non-Invasive Detection of Cardiovascular Risk in People Living with HIV in Miami
por: Salguero, Douglas, et al.
Publicado: (2020)

Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
por: Palacios, R, et al.
Publicado: (2010)

Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
por: Premer, Courtney, et al.
Publicado: (2015)

Abacavir forms novel cross-linking abacavir protein adducts in patients
por: Meng, Xiaoli, et al.
Publicado: (2014)

Molecular Recognition of the Antiretroviral Drug Abacavir: Towards the Development of a Novel Carbazole-Based Fluorosensor
por: Idzik, Krzysztof Ryszard, et al.
Publicado: (2011)

Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir
por: Padilla, Authors: Sergio, et al.
Publicado: (2011)

Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States
por: Dorjee, Kunchok, et al.
Publicado: (2021)

Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function
por: Guillemi, Silvia A, et al.
Publicado: (2016)

Abacavir-induced liver toxicity
por: Pezzani, Maria Diletta, et al.
Publicado: (2016)

Markers of inflammation and coagulation indicate a prothrombotic state in HIV-infected patients with long-term use of antiretroviral therapy with or without abacavir
por: Jong, Eefje, et al.
Publicado: (2010)

Sleep Debt and Postprandial Metabolic Function in Subclinical Cardiometabolic Pathophysiology
por: Hurwitz, Barry E.
Publicado: (2012)

Abacavir methanol 2.5-solvate
por: Pham, Phuong-Truc T.
Publicado: (2009)

Alopecia Areata Associated with Abacavir Therapy
por: Kim, Hee-Sung, et al.
Publicado: (2014)

Stress Degradation Behavior of Abacavir Sulfate and Development of a Suitable Stability-Indicating UHPLC Method for the Determination of Abacavir, its Related Substances, and Degradation Products
por: Vukkum, Pallavi, et al.
Publicado: (2012)

SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients
por: Kumar, P, et al.
Publicado: (2010)

Abacavir-Reactive Memory T Cells Are Present in Drug Naïve Individuals
por: Lucas, Andrew, et al.
Publicado: (2015)

Relaxation Effect of Abacavir on Rat Basilar Arteries
por: Li, Rachel Wai Sum, et al.
Publicado: (2015)

Structural Elements Recognized by Abacavir-Induced T Cells
por: Yerly, Daniel, et al.
Publicado: (2017)

Abacavir use is associated with increased prothrombin conversion
por: Yan, Qiuting, et al.
Publicado: (2023)

AOP-Based Transformation of Abacavir in Different Environments: Evolution Profile of Descyclopropyl-Abacavir and In Silico Toxicity Assessment of the Main Transformation Products
por: Evgenidou, Eleni, et al.
Publicado: (2023)

Abacavir/lamivudine combination in the treatment of HIV: a review
por: Sivasubramanian, Geetha, et al.
Publicado: (2010)

HLA-B*5701 testing to predict abacavir hypersensitivity
por: Ma, Joseph D., et al.
Publicado: (2010)

ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018)

The Role of Conformational Dynamics in Abacavir-Induced Hypersensitivity Syndrome
por: Fodor, James, et al.
Publicado: (2019)

Renal Function Declines More in Tenofovir- than Abacavir-Based Antiretroviral Therapy in Low-Body Weight Treatment-Naïve Patients with HIV Infection
por: Nishijima, Takeshi, et al.
Publicado: (2012)

Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
por: Janneh, Omar, et al.
Publicado: (2011)

Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan†
por: Kurita, Tomoko, et al.
Publicado: (2014)

Regional Experience of Abacavir: Valuable but Still has Unanswered Question
por: Bang, Ji Hwan
Publicado: (2017)

Proteomic Profiling and T Cell Receptor Usage of Abacavir Susceptible Subjects
por: Gall, Eline, et al.
Publicado: (2022)

Comparison of Chemical and Electrochemical Approaches to Abacavir Oxidative Stability Testing
por: Pražáková, Lucie, et al.
Publicado: (2023)

Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk
por: Rikhi, Rishi, et al.
Publicado: (2022)

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition: The Big Step Forward in Lipid Control
por: Rikhi, Rishi, et al.
Publicado: (2023)

Antiviral efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV-infected children and adolescents: a systematic review protocol
por: Adetokunboh, Olatunji O, et al.
Publicado: (2014)

Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis
por: Adetokunboh, Olatunji O., et al.
Publicado: (2015)

876. Renal Function, Lipid Profile, and Cardiovascular Events After Switching to Abacavir Containing Regimen in Antiretroviral-Therapy-Experienced People Living with HIV in Northern Thailand
por: Phudphong, Pitchaporn, et al.
Publicado: (2021)

Safety and Efficacy of Ziagen (Abacavir Sulfate) in HIV-Infected Korean Patients
por: Ann, Heawon, et al.
Publicado: (2017)

Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir
por: Rabie, Helena, et al.
Publicado: (2020)

Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA)
Publicado: (2008)

Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks
por: Tebas, Pablo, et al.
Publicado: (2015)

Work up of fatty liver by primary care physicians, review
por: Rikhi, Rishi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eos2s9mi4k6sitvs5tmng38a93